Skip to main content
Tech.euFundingExplorerBeta

Boehringer Ingelheim Venture Fund

Investor profile

Corporate VCVenture capital

Boehringer Ingelheim Venture Fund has backed 18 European tech companies across 24 funding rounds between 2013 and 2024, joining rounds totalling €365M. Most active in Healthtech. Data as of 4 Nov 2026.

Also recorded as: Boehringer Ingelheim

Deals
24
distinct rounds
Companies
18
backed
Active span
2013–2024
12 yrs
Total round €
€365M
sum of rounds joined

Deals by year

distinct rounds / year
Boehringer Ingelheim Venture Fund — deals by year — interactive chart.
Data table
Boehringer Ingelheim Venture Fund — deals by year
20131
20141
20152
20166
20171
20182
20191
20202
20215
20232
20241

Top sectors

by deals
Boehringer Ingelheim Venture Fund — top sectors — interactive chart.
Data table
Boehringer Ingelheim Venture Fund — top sectors
Healthtech24

Stages

by deals
Boehringer Ingelheim Venture Fund — stages — interactive chart.
Data table
Boehringer Ingelheim Venture Fund — stages
Series A8
Series B6
Seed3
Other3
Early VC2
Series C2

Countries

by deals
Boehringer Ingelheim Venture Fund — countries — interactive chart.
Data table
Boehringer Ingelheim Venture Fund — countries
Germany9
Switzerland5
France4
UK2
Israel1
Portugal1
Spain1
Sweden1

Co-investment network

shared rounds
Co-investment network — interactive chart.
Boehringer Ingelheim Venture Fund — 24 dealsBoehringer Ingelheim Venture FundHigh-Tech Gründerfonds (HTGF) — 7 shared deals · click to openHigh-Tech Gründerfonds (HTGF)NRW.BANK — 4 shared deals · click to openNRW.BANKWellington Partners — 4 shared deals · click to openWellington PartnersKurma Partners — 3 shared deals · click to openKurma PartnersForbion — 2 shared deals · click to openForbionGIMV — 2 shared deals · click to openGIMVIDInvest Partners — 2 shared deals · click to openIDInvest PartnersOxford University Innovation Fund — 2 shared deals · click to openOxford University Innovation FundParkwalk Advisors — 2 shared deals · click to openParkwalk AdvisorsPPF Group — 2 shared deals · click to openPPF GroupSeventure Partners — 2 shared deals · click to openSeventure PartnersSunstone Capital — 2 shared deals · click to openSunstone CapitalAdBio partners — 1 shared deals · click to openAdBio partnersArkin Holdings — 1 shared deals · click to openArkin HoldingsAthos Capital — 1 shared deals · click to openAthos CapitalBioMedPartners — 1 shared deals · click to openBioMedPartnersCaixa Capital Risc — 1 shared deals · click to openCaixa Capital RiscCarma Fund — 1 shared deals · click to openCarma Fund

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Frequent co-investors

shared rounds

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
Abalos TherapeuticsGermany1€43M
NBE-TherapeuticsSwitzerland3€40M
AignosticsGermany1€32M
AMALSwitzerland1€29M
RigontecGermany3€28M
DiogenXFrance1€28M
BrainomixUK2€27M
EyevensysFrance2€25M
STAT-DiagnosticaSpain1€25M
Imcheck TherapeuticsFrance1€20M
Topas TherapeuticsGermany1€18M
MetabomedIsrael1€16M
DopavisionGermany1€12M
tacalyxGermany1€7.0M
Asgard TherapeuticsSweden1€6.0M
C-mo Medical SolutionsPortugal1€4.8M
Amal TherapeuticsSwitzerland1€2.8M
Acousia TherapeuticsGermany1€2.5M

Biggest deals

top 10 by amount
CompanyStageAmountDate
Abalos TherapeuticsSeries A€43M2021-10
AignosticsSeries B€32M2024-10
AMALSeries B€29M2018-11
DiogenXSeries A€28M2023-05
EyevensysSeries B€25M2020-08
STAT-DiagnosticaSeries C€25M2016-04
Imcheck TherapeuticsOther€20M2017-05
BrainomixSeries B€19M2021-12
NBE-TherapeuticsSeries C€19M2020-10
NBE-TherapeuticsSeries B€19M2016-11
← Back to investors